AAA names apoints four board members
This article was originally published in Scrip
Saint-Genis-Pouilly, France-based Advanced Accelerator Applications, a specialist company developing molecular nuclear medicines, has named four industry experts to its board of directors. They are: Dr Yvonne Greenstreet, who was a senior vice-president and the head of medicines development at Pfizer from 2010 to 2013. Dr Greenstreet also currently serves on the advisory board of the Bill and Melinda Gates Foundation and as a member of the board of directors of Pacira. Also joining the board is Steve Gannon, a senior vice-president, chief financial officer and treasurer at Aptalis Pharma; Leopoldo Zambeletti, an independent strategic advisor to life science companies on Merger and Acquisitions, out-licensing deals and financing strategy; and Christian Merle, a managing partner at Merle & Partners, advisory.
You may also be interested in...
Diversity in all forms is critical to innovation in health care, says AstraZeneca’s chief medical officer, Ann Taylor. In an exclusive interview, she talks about the company’s work in mentoring and education, and why tackling issues around diversity and inclusion must be driven by the C-suite alongside community initiatives.
A selection of articles you might have missed from October 2020, including exclusive interviews with industry leaders and a deeper dive into the Femtech market.
An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.